SLC35A2 and colorectal carcinoma: In conclusion, the present study suggests that SLC35A2 is up-regulated in CRC tissues and cells, and the level of SLC35A2 is significantly related to the pathological stages of CRC patients, which may serve as prognostic markers in CRC and provide a forward-looking view for CRC diagnosis and therapy.